Ling Li
About
Ling Li is a scholar working on Statistics, Probability and Uncertainty, Surgery and Endocrinology, Diabetes and Metabolism.
According to data from OpenAlex, Ling Li has authored 118 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Statistics, Probability and Uncertainty, 24 papers in Surgery and 17 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ling Li's work include Meta-analysis and systematic reviews (27 papers), Health Systems, Economic Evaluations, Quality of Life (16 papers) and Statistical Methods in Clinical Trials (13 papers). Ling Li is often cited by papers focused on Meta-analysis and systematic reviews (27 papers), Health Systems, Economic Evaluations, Quality of Life (16 papers) and Statistical Methods in Clinical Trials (13 papers). Ling Li collaborates with scholars based in China, Canada and United States. Ling Li's co-authors include Xin Sun, Sheyu Li, Haoming Tian, Qinjie Wu, Changyang Gong, Ke Deng, Yuquan Wei, Jiali Liu, Ning Wang and Shihong Nie and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The Journal of Immunology.
In The Last Decade
Ling Li
112 papers receiving 3.1k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ling Li China | 27 | 948 | 862 | 425 | 356 | 335 | 118 | 3.2k | ||
| Sheyu Li China | 33 | 1.6k 1.7× | 836 1.0× | 800 1.9× | 352 1.0× | 502 1.5× | 133 | 3.9k | ||
| Christine Clar United Kingdom | 29 | 1.2k 1.2× | 741 0.9× | 507 1.2× | 149 0.4× | 461 1.4× | 51 | 3.1k | ||
| Pamela Royle United Kingdom | 37 | 1.4k 1.5× | 1.5k 1.7× | 477 1.1× | 296 0.8× | 725 2.2× | 78 | 4.4k | ||
| Muhammad Jawad Hashim United Arab Emirates | 18 | 1.0k 1.1× | 425 0.5× | 662 1.6× | 548 1.5× | 609 1.8× | 82 | 4.2k | ||
| Gang Chen China | 29 | 528 0.6× | 499 0.6× | 543 1.3× | 142 0.4× | 413 1.2× | 197 | 3.7k | ||
| Giuseppina Russo Italy | 34 | 1.6k 1.7× | 661 0.8× | 704 1.7× | 54 0.2× | 487 1.5× | 150 | 3.8k | ||
| Morteza Ghojazadeh Iran | 31 | 403 0.4× | 875 1.0× | 520 1.2× | 282 0.8× | 489 1.5× | 347 | 4.3k | ||
| Iona Y. Millwood United Kingdom | 31 | 472 0.5× | 419 0.5× | 619 1.5× | 126 0.4× | 707 2.1× | 100 | 3.0k | ||
| Nestoras Mathioudakis United States | 26 | 1.6k 1.7× | 513 0.6× | 222 0.5× | 110 0.3× | 227 0.7× | 93 | 2.5k | ||
| Abbasali Keshtkar Iran | 32 | 245 0.3× | 654 0.8× | 538 1.3× | 268 0.8× | 568 1.7× | 230 | 4.1k |
Countries citing papers authored by Ling Li
Since
Specialization
Citations
This map shows the geographic impact of Ling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Li more than expected).
Fields of papers citing papers by Ling Li
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Ling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Li. The network helps show where Ling Li may publish in the future.
Co-authorship network of co-authors of Ling Li
This figure shows the co-authorship network connecting the top 25 collaborators of Ling Li. A scholar is included among the top collaborators of Ling Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Li. Ling Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Wang, Yuning, Minghong Yao, Jiali Liu, et al.. (2024). Adaptive designs were primarily used but inadequately reported in early phase drug trials. BMC Medical Research Methodology. 24(1). 130–130.
2.
Yao, Minghong, et al.. (2023). Methods for the Inclusion of Real-World Evidence in a Rare Events Meta-Analysis of Randomized Controlled Trials. Journal of Clinical Medicine. 12(4). 1690–1690.
3.
Li, Qianrui, Ling Li, Bin Ma, et al.. (2022). Toward better translation of clinical research evidence into rapid recommendations for traditional Chinese medicine interventions: A methodological framework. Integrative Medicine Research. 11(3). 100841–100841.
4.
Wang, Wen, Mei Liu, Jiayue Xu, et al.. (2022). Impact of time-varying exposure on estimated effects in observational studies using routinely collected data: protocol for a cross-sectional study. BMJ Open. 12(7). e062572–e062572.
5.
Ma, Yu, Ke Deng, Jiali Liu, et al.. (2022). The add-on effects of Danhong injection among patients with ischemic stroke receiving Western medicines: A systematic review and meta-analysis. Frontiers in Pharmacology. 13. 937369–937369.
6.
Li, Ling, Jiali Liu, Xiujuan Li, et al.. (2021). The Preventive Value of Acupoint Sensitization for Patients with Stable Angina Pectoris: A Randomized, Double-Blind, Positive-Controlled, Multicentre Trial. Evidence-based Complementary and Alternative Medicine. 2021. 1–9.
7.
Lü, Lin, Ling Li, Yining Wang, et al.. (2021). Clinical Characteristics for the Improvement of Cushing's Syndrome Complicated With Cardiomyopathy After Treatment With a Literature Review. Frontiers in Cardiovascular Medicine. 8. 777964–777964.
8.
Wang, Xu, Jian Cheng, Ling Li, et al.. (2020). Impact of temperature variability on childhood allergic rhinitis in a subtropical city of China. BMC Public Health. 20(1). 1418–1418.
9.
Li, Ling, Ke Deng, Jason W. Busse, et al.. (2020). A systematic survey showed important limitations in the methods for assessing drug safety among systematic reviews. Journal of Clinical Epidemiology. 123. 80–90.
10.
Jia, Pengli, Jiali Liu, Ling Li, et al.. (2020). Acupuncture for knee osteoarthritis with sensitized acupoints: results from a pilot, feasibility randomized controlled trial. Pilot and Feasibility Studies. 6(1). 144–144.
11.
Kahale, Lara A, Assem M. Khamis, Batoul Diab, et al.. (2020). Potential impact of missing outcome data on treatment effects in systematic reviews: imputation study. BMJ. 370. m2898–m2898.
12.
Deng, Ke, Ling Li, Chang Xu, et al.. (2019). Criteria and clinical predictors of high ovarian response: a systematic review. 39(5). 376–384.
13.
Li, Qianrui, Xiaodan Li, Jing Wang, et al.. (2019). Diagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statements. BMJ Open. 9(8). e026677–e026677.
14.
Wang, Chengshi, Ling Li, Shuyun Liu, et al.. (2018). GLP-1 receptor agonist ameliorates obesity-induced chronic kidney injury via restoring renal metabolism homeostasis. PLoS ONE. 13(3). e0193473–e0193473.
15.
Wu, Yuan, Xun Yao, Giacomo Vespasiani, et al.. (2018). Correction: Mobile App-Based Interventions to Support Diabetes Self-Management: A Systematic Review of Randomized Controlled Trials to Identify Functions Associated with Glycemic Efficacy. JMIR mhealth and uhealth. 6(1). e20–e20.
16.
Liu, Dan, Xiaodan Li, Yonggang Zhang, et al.. (2018). Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis. Drug Design Development and Therapy. Volume 12. 1685–1695.
17.
Jia, Qingyi, Xiaodan Li, Ying Liu, et al.. (2018). Incidental thyroid carcinoma in surgery-treated hyperthyroid patients with Graves’ disease: a systematic review and meta-analysis of cohort studies. Cancer Management and Research. Volume 10. 1201–1207.
18.
Li, Ling, Chang Xu, Ke Deng, et al.. (2018). The reporting of safety among drug systematic reviews was poor before the implementation of the PRISMA harms checklist. Journal of Clinical Epidemiology. 105. 125–135.
19.
Wu, Yuan, Xun Yao, Giacomo Vespasiani, et al.. (2017). Mobile App-Based Interventions to Support Diabetes Self-Management: A Systematic Review of Randomized Controlled Trials to Identify Functions Associated with Glycemic Efficacy. JMIR mhealth and uhealth. 5(3). e35–e35.
20.
Yin, Tao, Guoping Wang, Sisi He, et al.. (2016). Malignant Pleural Effusion and ascites Induce Epithelial-Mesenchymal Transition and Cancer Stem-like Cell Properties via the Vascular Endothelial Growth Factor (VEGF)/Phosphatidylinositol 3-Kinase (PI3K)/Akt/Mechanistic Target of Rapamycin (mTOR) Pathway. Journal of Biological Chemistry. 291(52). 26750–26761.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Sheyu Li Breakdown of academic impact, for papers by Christine Clar Breakdown of academic impact, for papers by Pamela Royle Breakdown of academic impact, for papers by Muhammad Jawad Hashim Breakdown of academic impact, for papers by Gang Chen Breakdown of academic impact, for papers by Giuseppina Russo Breakdown of academic impact, for papers by Morteza Ghojazadeh Breakdown of academic impact, for papers by Iona Y. Millwood Breakdown of academic impact, for papers by Nestoras Mathioudakis Breakdown of academic impact, for papers by Abbasali Keshtkar